BACKGROUND: The question of how smoking, COPD, and other chronic diseases are related remains unresolved. Therefore, we examined relationships between smoking, COPD, and 10 other chronic diseases and assessed the prevalence of co-morbid chronic conditions among people with COPD. METHODS: We analyzed cross-sectional data from 405,856 US adults aged 18 years or older in the 2011 Behavioral Risk Factor Surveillance System. We used log-linear regression to estimate prevalence ratios (PRs) and their corresponding 95% confidence intervals (CIs) for these relationships adjusting for age, gender, race/ethnicity, marital status, educational attainment, annual household income, and health insurance coverage. RESULTS: Overall, 17.5% reported being current cigarette smokers, 6.9% reported having COPD, and 71.2% reported another chronic condition. After age-adjustment, prevalence of COPD was 14.1% (adjusted PR = 3.9; 95% CI: 3.7, 4.1) among current smokers and 7.1% (adjusted PR = 2.5; 95% CI: 2.4, 2.7) among former smokers compared to 2.9% among never smokers. The most common chronic conditions among current smokers after age-adjustment were high cholesterol (36.7%), high blood pressure (34.6%), arthritis (29.4%), depression (27.4%), and asthma (16.9%). In separate multivariable models, smoking and COPD were associated with each of the 10 other chronic conditions (p < 0.05), which also included cancer, coronary heart disease, diabetes, kidney disease, and stroke; COPD modified associations between smoking and co-morbidities, while smoking did not modify associations between COPD and co-morbidities. CONCLUSIONS: Our findings confirm previous evidence and highlight the continuing importance of comprehensive care coordination for people with COPD and co-morbid chronic conditions and also tobacco prevention and control strategies.
BACKGROUND: The question of how smoking, COPD, and other chronic diseases are related remains unresolved. Therefore, we examined relationships between smoking, COPD, and 10 other chronic diseases and assessed the prevalence of co-morbid chronic conditions among people with COPD. METHODS: We analyzed cross-sectional data from 405,856 US adults aged 18 years or older in the 2011 Behavioral Risk Factor Surveillance System. We used log-linear regression to estimate prevalence ratios (PRs) and their corresponding 95% confidence intervals (CIs) for these relationships adjusting for age, gender, race/ethnicity, marital status, educational attainment, annual household income, and health insurance coverage. RESULTS: Overall, 17.5% reported being current cigarette smokers, 6.9% reported having COPD, and 71.2% reported another chronic condition. After age-adjustment, prevalence of COPD was 14.1% (adjusted PR = 3.9; 95% CI: 3.7, 4.1) among current smokers and 7.1% (adjusted PR = 2.5; 95% CI: 2.4, 2.7) among former smokers compared to 2.9% among never smokers. The most common chronic conditions among current smokers after age-adjustment were high cholesterol (36.7%), high blood pressure (34.6%), arthritis (29.4%), depression (27.4%), and asthma (16.9%). In separate multivariable models, smoking and COPD were associated with each of the 10 other chronic conditions (p < 0.05), which also included cancer, coronary heart disease, diabetes, kidney disease, and stroke; COPD modified associations between smoking and co-morbidities, while smoking did not modify associations between COPD and co-morbidities. CONCLUSIONS: Our findings confirm previous evidence and highlight the continuing importance of comprehensive care coordination for people with COPD and co-morbid chronic conditions and also tobacco prevention and control strategies.
Entities:
Keywords:
COPD; chronic disease; cross-sectional studies; smoking; tobacco use
Authors: J G van Manen; P J Bindels; C J IJzermans; J S van der Zee; B J Bottema; E Schadé Journal: J Clin Epidemiol Date: 2001-03 Impact factor: 6.437
Authors: Lowie E G W Vanfleteren; Martijn A Spruit; Miriam Groenen; Swetlana Gaffron; Vanessa P M van Empel; Piet L B Bruijnzeel; Erica P A Rutten; Jos Op 't Roodt; Emiel F M Wouters; Frits M E Franssen Journal: Am J Respir Crit Care Med Date: 2013-04-01 Impact factor: 21.405
Authors: Miguel Divo; Claudia Cote; Juan P de Torres; Ciro Casanova; Jose M Marin; Victor Pinto-Plata; Javier Zulueta; Carlos Cabrera; Jorge Zagaceta; Gary Hunninghake; Bartolome Celli Journal: Am J Respir Crit Care Med Date: 2012-05-03 Impact factor: 21.405
Authors: Kerry Schnell; Carlos O Weiss; Todd Lee; Jerry A Krishnan; Bruce Leff; Jennifer L Wolff; Cynthia Boyd Journal: BMC Pulm Med Date: 2012-07-09 Impact factor: 3.317
Authors: Richard A Goodman; Samuel F Posner; Elbert S Huang; Anand K Parekh; Howard K Koh Journal: Prev Chronic Dis Date: 2013-04-25 Impact factor: 2.830
Authors: Tatsiana Beiko; Michael G Janech; Alexander V Alekseyenko; Carl Atkinson; Harvey O Coxson; Jeremy L Barth; Sarah E Stephenson; Carole L Wilson; Lynn M Schnapp; Alan Barker; Mark Brantly; Robert A Sandhaus; Edwin K Silverman; James K Stoller; Bruce Trapnell; Strange Charlie Journal: Chronic Obstr Pulm Dis Date: 2017-07-15
Authors: Uma S Nair; Melanie L Bell; Nicole P Yuan; Betsy C Wertheim; Cynthia A Thomson Journal: Public Health Rep Date: 2018 Mar/Apr Impact factor: 2.792
Authors: Timothy J Cunningham; Paul I Eke; Earl S Ford; Israel T Agaku; Anne G Wheaton; Janet B Croft Journal: J Periodontol Date: 2015-11-05 Impact factor: 6.993
Authors: Sophia Kwon; Myeonggyun Lee; George Crowley; Theresa Schwartz; Rachel Zeig-Owens; David J Prezant; Mengling Liu; Anna Nolan Journal: Am J Respir Crit Care Med Date: 2021-11-01 Impact factor: 21.405